InsidersTradesSigma
Scandinavian ChemoTech AB Stock: price and management transactions · Finland · FIN-FSA
Follow the Scandinavian ChemoTech AB share price and the full management transaction log of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Scandinavian ChemoTech AB has published 2 public disclosures. Market capitalisation: €98.3m. The latest transaction was filed on 18 June 2026 (Purchase). Among the most active insiders: Rolf Ehrnström. Every trade is accessible without an account.
2
Insider Decl.
0
Thresholds
€95,854
2 ops.
Buy Volume
·
0 ops.
Sell Volume
19Σ signal
Fundamental score
Ranked 22,102 of 25,899 companies
26.3
score / 100
Value21
Quality32
FCF yld-4.3%
Earn yld-8.4%
EV/EBITDA·
ROE-236%
Gross mgn84%
Net mgn-66%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 June 2026
Declarations2 total
74,626 shares@ SEK 3.350.024% mcap100.0% of flowAktieFI:csv-85d979fefbb0d4a7bde6
Ideal exit: 12 Mar 2027 (T+270)
238,805 shares@ SEK 3.35100.0% of flowAktieFI:csv-440fd9a78f695a4982a0
Ideal exit: 13 Mar 2027 (T+270)
2 of 2 declarations
About Scandinavian ChemoTech AB
Scandinavian ChemoTech AB is a company focused on developing innovative cancer treatments. It specializes in therapeutic solutions based on electroporation technology.